Lakeland Industries (NASDAQ:LAKE - Get Free Report) is projected to release its Q2 2027 results after the market closes on Wednesday, September 9th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $51.4820 million for the quarter. Interested persons can check the company's upcoming Q2 2027 earning summary page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 4:30 PM ET.
Lakeland Industries (NASDAQ:LAKE - Get Free Report) last posted its earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.18. The firm had revenue of $47.42 million for the quarter, compared to analyst estimates of $47.36 million. Lakeland Industries had a negative return on equity of 6.64% and a negative net margin of 10.87%. On average, analysts expect Lakeland Industries to post $-0 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Lakeland Industries Stock Performance
NASDAQ LAKE opened at $11.74 on Wednesday. The company has a market cap of $115.87 million, a P/E ratio of -5.51 and a beta of 1.45. The company has a debt-to-equity ratio of 0.20, a current ratio of 3.09 and a quick ratio of 1.34. The stock has a 50-day moving average of $11.49 and a two-hundred day moving average of $10.25. Lakeland Industries has a 1-year low of $7.15 and a 1-year high of $18.00.
Wall Street Analyst Weigh In
LAKE has been the topic of several research reports. DA Davidson increased their price target on shares of Lakeland Industries from $14.00 to $18.00 and gave the stock a "buy" rating in a research report on Thursday, June 11th. Wall Street Zen raised shares of Lakeland Industries from a "sell" rating to a "hold" rating in a research note on Sunday, July 12th. Finally, Weiss Ratings upgraded shares of Lakeland Industries from a "sell (e+)" rating to a "sell (d-)" rating in a report on Monday, June 29th. Three analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $16.00.
View Our Latest Stock Analysis on Lakeland Industries
Institutional Trading of Lakeland Industries
Hedge funds have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC acquired a new position in Lakeland Industries during the 1st quarter worth approximately $164,000. Goldman Sachs Group Inc. raised its holdings in shares of Lakeland Industries by 42.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 44,435 shares of the medical instruments supplier's stock valued at $902,000 after purchasing an additional 13,219 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of Lakeland Industries by 107.7% in the 1st quarter. Jane Street Group LLC now owns 40,180 shares of the medical instruments supplier's stock valued at $816,000 after purchasing an additional 20,832 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Lakeland Industries by 115.9% during the 2nd quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier's stock worth $2,964,000 after purchasing an additional 116,901 shares during the last quarter. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Lakeland Industries during the 2nd quarter worth $59,000. Institutional investors and hedge funds own 71.69% of the company's stock.
Lakeland Industries Company Profile
(
Get Free Report)
Lakeland Industries, Inc NASDAQ: LAKE is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company's expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.
The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lakeland Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lakeland Industries wasn't on the list.
While Lakeland Industries currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.